COVID-19 and diabetes: What does the clinician need to know?

In December 2019, a series of pneumonia cases of unknown cause was reported in Wuhan, Hubei, China. Shortly a novel coronavirus was isolated from respiratory tract samples named as SARS-CoV-2 (severe acute respiratory syndrome coronavirus-2). The new virus rapidly spread globally resulting in a pandemic. SARS-CoV-2 belongs to betacoronavirus as the severe acute respiratory syndrome (SARS) and the middle east respiratory syndrome (MERS) viruses responsible for serious outbreaks in China in 2002 –2003 and in the Middle East in 2012, respectively [1].

Source: Primary Care Diabetes - July 2, 2020 Category: Primary Care Authors: Eleni Papadokostaki, Nikolaos Tentolouris, Evangelos Liberopoulos Tags: Review Source Type: research